Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128614) titled 'Evaluation of the efficacy and safety of epidural hydromorphone for analgesia in radical esophagectomy' on July 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Esophageal cancer is the eighth most common cancer and the sixth leading cause of cancer death worldwide. Esophageal cancer is characterized by insidious onset, rapid progression, and poor prognosis, with a marked disparity in outcomes between early and late detection. The 5-year survival rate for patients with early-stage disease can reach 90%, whereas for those with advanced-stage disea...